Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial

ObjectivesTo the best of our knowledge, there is no published study regarding use of IFN {beta}-1a in the treatment of severe COVID-19. In this randomized clinical trial efficacy and safety of IFN {beta}-1a has been evaluated in patients with severe COVID-19. MethodsForty-two patients in the interferon group received IFN {beta}-1a in... Show more